{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:56:12Z","timestamp":1770141372553,"version":"3.49.0"},"reference-count":237,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DKR01123094"],"award-info":[{"award-number":["DKR01123094"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3DK136705"],"award-info":[{"award-number":["UH3DK136705"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RDK126454"],"award-info":[{"award-number":["RDK126454"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK118529"],"award-info":[{"award-number":["R01DK118529"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK123094"],"award-info":[{"award-number":["R01DK123094"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["22H02866"],"award-info":[{"award-number":["22H02866"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX004536"],"award-info":[{"award-number":["I01BX004536"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CSR&D I01CX002516"],"award-info":[{"award-number":["CSR&D I01CX002516"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jcyt.2024.11.008","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:32:34Z","timestamp":1732055554000},"page":"259-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights"],"prefix":"10.1016","volume":"27","author":[{"given":"Hongjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-7576","authenticated-orcid":false,"given":"Rachele","family":"Ciccocioppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Shoeibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5961-8281","authenticated-orcid":false,"given":"Giulia","family":"De Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2943-8768","authenticated-orcid":false,"given":"Takafumi","family":"Tonouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaito","family":"Furuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-8416","authenticated-orcid":false,"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4531-8747","authenticated-orcid":false,"given":"Rosanna","family":"Di Tinco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.11.008_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12793\/tcp.2022.30.e2","article-title":"Comparison of international guidelines for early-phase clinical trials of cellular and gene therapy products","volume":"30","author":"Shin","year":"2022","journal-title":"Transl Clin Pharmacol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40778-021-00196-4","article-title":"Regulatory framework for academic investigator-sponsored investigational new drug development of cell and gene therapies in the USA","volume":"7","author":"Dasgupta","year":"2021","journal-title":"Curr Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0003","series-title":"Center for Biologics Evaluation and Research","first-page":"1","article-title":"Food and Drug Administration, C.f.B.E.a. research, preclinical assessment of investigational cellular and gene therapy products, guidance for industry","year":"2013"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0004","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/cgt.2015.58","article-title":"Gene therapy for cancer: regulatory considerations for approval","volume":"22","author":"Husain","year":"2015","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0005","first-page":"683","article-title":"Regulatory considerations for gene therapy products in the US, EU, and Japan","volume":"90","author":"Halioua-Haubold","year":"2017","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0006","series-title":"Interpreting sameness of gene therapy products under the orphan drug regulations","year":"2021"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0007","series-title":"Considerations for allogeneic pancreatic islet cell products","first-page":"1","year":"2009"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0008","series-title":"Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT\/Ps)","first-page":"1","volume":"1448","year":"2007"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0009","series-title":"Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous","first-page":"1","year":"2020"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0010","series-title":"ICH guideline S6 (R1) \u2013 preclinical safety evaluation of biotechnology-derived pharmaceuticals","first-page":"22","author":"Agency","year":"2011"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0011","unstructured":"E.M. Agency, Guideline on human cell-based medicinal products, committee for medicinal product for human use (CHMP) 2008."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0012","unstructured":"E.M. Agency, Reflection paper on stem cell-based medicinal products, committee for advanced therapies (CAT) 2011, p. 14."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0013","unstructured":"E.M. Agency, Guideline on the quality, non-clinical and clinical aspects of gene therapy medicinal products, committee for advanced therapies (CAT) 2018, p. 46."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0014","unstructured":"L.a.W. Ministry of Health, Guidelines on clinical research using human stem cells, 2006, p. 41."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0015","unstructured":"L.a.W. Ministry of Health, Guideline on ensuring the quality and safety of gene therapy products, 2019."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0016","unstructured":"Food and Drug Administration, part 58\u2014good laboratory practice for nonclinical laboratory studies, December 22, 1978. https:\/\/www.ecfr.gov\/current\/title-21\/part-58."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0017","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.stemcr.2023.05.003","article-title":"Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells","volume":"18","author":"Hirai","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0018","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biologicals.2018.08.004","article-title":"Report of the international conference on manufacturing and testing of pluripotent stem cells","volume":"56","author":"Abbot","year":"2018","journal-title":"Biologicals"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0019","doi-asserted-by":"crossref","first-page":"e00863","DOI":"10.1002\/prp2.863","article-title":"Strategies to apply 3Rs in preclinical testing","volume":"9","author":"Gorzalczany","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0020","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2012.12.043","article-title":"Models of acute and chronic pancreatitis","volume":"144","author":"Lerch","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5946\/ce.2014.47.3.212","article-title":"Experimental models of pancreatitis","volume":"47","author":"Hyun","year":"2014","journal-title":"Clin Endosc"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"G. acute pancreatitis classification working, classification of acute pancreatitis\u20142012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0023","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41575-019-0158-2","article-title":"New insights into acute pancreatitis","volume":"16","author":"Lee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0024","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01852290","article-title":"Experimental pancreatitis in the rat. Changes in pulmonary phospholipids during sodium taurocholate-induced acute pancreatitis","volume":"182","author":"Aho","year":"1983","journal-title":"Res Exp Med (Berl)"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00365528009181493","article-title":"Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis","volume":"15","author":"Aho","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0026","first-page":"112","article-title":"Choline metabolism. I. The occurrence and prevention of hemorrhagic degeneration in young rats on a low choline diet","volume":"32","year":"1974","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0027","first-page":"465","article-title":"Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet","volume":"79","author":"Lombardi","year":"1975","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0028","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jn\/114.3.467","article-title":"Effects of injecting excess arginine on rat pancreas","volume":"114","author":"Mizunuma","year":"1984","journal-title":"J Nutr"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0029","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01537416","article-title":"New model of acute necrotizing pancreatitis induced by excessive doses of arginine in rats","volume":"35","author":"Tani","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0030","doi-asserted-by":"crossref","first-page":"G343","DOI":"10.1152\/ajpgi.00372.2015","article-title":"Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis","volume":"311","author":"Zhan","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0031","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1089\/ars.2011.4065","article-title":"The crucial role of early mitochondrial injury in L-lysine-induced acute pancreatitis","volume":"15","author":"Biczo","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0032","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/CCM.0b013e31817d7f5c","article-title":"A new severe acute necrotizing pancreatitis model induced by L-ornithine in rats","volume":"36","author":"Rakonczay","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0033","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000058033","article-title":"Animal models in alcoholic pancreatitis\u2014what can we learn?","volume":"2","author":"Schneider","year":"2002","journal-title":"Pancreatology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0034","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006676-199611000-00005","article-title":"Infectious causes of acute pancreatitis","volume":"13","author":"Parenti","year":"1996","journal-title":"Pancreas"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0035","first-page":"331","article-title":"Pathological changes in the pancreas of mice following infection with Coxsackie B viruses","volume":"57","author":"Lansdown","year":"1976","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0036","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.apsb.2016.09.003","article-title":"Establishment of a new acute-on-chronic liver failure model","volume":"7","author":"Li","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0037","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/13651820500467358","article-title":"Review of experimental animal models of acute pancreatitis","volume":"8","author":"Su","year":"2006","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0038","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/dia.2005.7.948","article-title":"Blood glucose-lowering activity of a hyaluronan-insulin complex after oral administration to rats with diabetes","volume":"7","author":"Jederstrom","year":"2005","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0039","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10620-017-4510-5","article-title":"Epidemiology of recurrent acute and chronic pancreatitis: similarities and differences","volume":"62","author":"Machicado","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0040","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1089\/ars.2011.4079","article-title":"The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells","volume":"15","author":"Apte","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0041","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.7150\/jca.38616","article-title":"Molecular mechanism of pancreatic stellate cells activation in chronic pancreatitis and pancreatic cancer","volume":"11","author":"Jin","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0042","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpgasthep0025","article-title":"Mechanisms of disease: advances in understanding the mechanisms leading to chronic pancreatitis","volume":"1","author":"Whitcomb","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0043","doi-asserted-by":"crossref","first-page":"G700","DOI":"10.1152\/ajpgi.00502.2005","article-title":"A new model of chronic pancreatitis in rats","volume":"291","author":"Yamamoto","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPA.0b013e31816459b7","article-title":"Does chronic ethanol intake cause chronic pancreatitis?: Evidence and mechanism","volume":"37","author":"Li","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1530-0277.2010.01408.x","article-title":"Investigating the pathobiology of alcoholic pancreatitis","volume":"35","author":"Pandol","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0046","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0016-5085(97)70049-0","article-title":"Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride","volume":"112","author":"Sparmann","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0047","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/exmp.1994.1007","article-title":"Pancreatic changes elicited by chronic administration of excess L-arginine","volume":"60","author":"Weaver","year":"1994","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0048","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MPA.0000000000001335","article-title":"Animal models: challenges and opportunities to determine optimal experimental models of pancreatitis and pancreatic cancer","volume":"48","author":"Saloman","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0049","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1755-1536-4-26","article-title":"Animal models for investigating chronic pancreatitis","volume":"4","author":"Aghdassi","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0050","unstructured":"A.G. Reed, Fred., Animal models of chronic pancreatitis., Pancreapedia: exocrine pancreas knowledge base 2014; 1:1-21."},{"key":"10.1016\/j.jcyt.2024.11.008_bib0051","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1038\/s41598-023-35820-2","article-title":"Chemical pancreatectomy in non-human primates ablates the acini and ducts and enhances beta-cell function","volume":"13","author":"Kalsi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0052","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41395-018-0146-0","article-title":"Autoimmune pancreatitis","volume":"113","author":"Nagpal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0053","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajpath.2018.05.022","article-title":"Tumefactive inflammatory diseases of the pancreas","volume":"189","author":"Zen","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0054","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MPA.0b013e3181e4d9e5","article-title":"G. autoimmune pancreatitis international cooperative study, histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document","volume":"39","author":"Chari","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0055","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39209","article-title":"Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease","volume":"67","author":"Akiyama","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0056","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.2009.200972","article-title":"Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease","volume":"59","author":"Akitake","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0057","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cei.12641","article-title":"Immunology of IgG4-related disease","volume":"181","author":"Della-Torre","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0058","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0059","doi-asserted-by":"crossref","first-page":"15311","DOI":"10.1002\/cpim.41","article-title":"Autoimmune pancreatitis mouse model","volume":"120","author":"Kamata","year":"2018","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.1992.tb06879.x","article-title":"Spontaneous development of pancreatitis in the MRL\/Mp strain of mice in autoimmune mechanism","volume":"89","author":"Kanno","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0061","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2249.2002.01881.x","article-title":"A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid","volume":"129","author":"Qu","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0062","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/MPA.0b013e31824a0e58","article-title":"Comparative study on experimental autoimmune pancreatitis and its extrapancreatic involvement in mice","volume":"41","author":"Yamashina","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0063","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MPA.0b013e3181bab5e2","article-title":"Analysis of humoral immune response in experimental autoimmune pancreatitis in mice","volume":"39","author":"Asada","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0064","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.1500971","article-title":"Plasmacytoid dendritic cell activation and IFN-alpha production are prominent features of murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis","volume":"195","author":"Arai","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0065","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.it.2018.09.005","article-title":"Mechanistic insights into autoimmune pancreatitis and IgG4-related disease","volume":"39","author":"Watanabe","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0066","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng1096-141","article-title":"Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene","volume":"14","author":"Whitcomb","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0067","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/76088","article-title":"Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis","volume":"25","author":"Witt","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0068","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng.2007.44","article-title":"(CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis","volume":"40","author":"Rosendahl","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0069","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gut.2005.064808","article-title":"Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls","volume":"54","author":"Weiss","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0070","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00439-022-02436-x","article-title":"Trypsinogen (PRSS1 and PRSS2) gene dosage correlates with pancreatitis risk across genetic and transgenic studies: a systematic review and re-analysis","volume":"141","author":"Zou","year":"2022","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0071","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1038\/s41598-023-39178-3","article-title":"Reg family proteins contribute to inflammation and pancreatic stellate cells activation in chronic pancreatitis","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0072","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129717","article-title":"Natural single-nucleotide deletion in chymotrypsinogen C gene increases severity of secretagogue-induced pancreatitis in C57BL\/6 mice","volume":"4","author":"Geisz","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0073","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2017.10.018","article-title":"Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice","volume":"154","author":"Sendler","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165987","article-title":"Pancreas-specific deletion of protein kinase D attenuates inflammation, necrosis, and severity of acute pancreatitis","volume":"1867","author":"Yuan","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/cells9061407","article-title":"Knockout of the mitochondrial calcium uniporter strongly suppresses stimulus-metabolism coupling in pancreatic acinar cells but does not reduce severity of experimental acute pancreatitis","volume":"9","author":"Chvanov","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0076","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1172\/JCI134111","article-title":"TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation","volume":"130","author":"Swain","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0077","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132585","article-title":"Pancreas-specific CHRM3 activation causes pancreatitis in mice","volume":"6","author":"Wan","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0078","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.gastro.2015.01.012","article-title":"Impaired autophagy triggers chronic pancreatitis: lessons from pancreas-specific atg5 knockout mice","volume":"148","author":"Gukovsky","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0079","doi-asserted-by":"crossref","first-page":"E6166","DOI":"10.1073\/pnas.1519384112","article-title":"Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress","volume":"112","author":"Antonucci","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0080","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1080\/15548627.2020.1715047","article-title":"Transgenic expression of GFP-LC3 perturbs autophagy in exocrine pancreas and acute pancreatitis responses in mice","volume":"16","author":"Mareninova","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0081","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1080\/15548627.2019.1596486","article-title":"Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0082","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jcmgh.2015.07.006","article-title":"Lysosome associated membrane proteins maintain pancreatic acinar cell homeostasis: LAMP-2 deficient mice develop pancreatitis","volume":"1","author":"Mareninova","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0083","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcmgh.2020.10.008","article-title":"Deficient endoplasmic reticulum acetyl-CoA import in pancreatic acinar cells leads to chronic pancreatitis","volume":"11","author":"Cooley","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0084","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41467-021-20904-2","article-title":"NUPR1 is a critical repressor of ferroptosis","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149539","article-title":"Loss of miR-29a\/b1 promotes inflammation and fibrosis in acute pancreatitis","volume":"6","author":"Dey","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0086","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42826-021-00101-4","article-title":"Experimental animal models for diabetes and its related complications-a review","volume":"37","author":"Kottaisamy","year":"2021","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0087","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ecl.2010.05.001","article-title":"Use of nonobese diabetic mice to understand human type 1 diabetes","volume":"39","author":"Thayer","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0088","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0952-7915(94)90011-6","article-title":"Genetic and pathogenic basis of autoimmune diabetes in NOD mice","volume":"6","author":"Serreze","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0089","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0952-7915(98)80092-7","article-title":"Genetics of autoimmune diabetes in animal models","volume":"10","author":"McDuffie","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0091","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000060488","article-title":"Localising quantitative trait loci in the NOD mouse model of type 1 diabetes","volume":"1","author":"Lyons","year":"1999","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0092","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0952-7915(98)80088-5","article-title":"The role of MHC class II molecules in susceptibility and resistance to autoimmunity","volume":"10","author":"McDevitt","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0093","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1073\/pnas.95.21.12538","article-title":"Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement","volume":"95","author":"DiLorenzo","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0094","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ceb.2011.10.003","article-title":"Integrating levels of complexity: a trend in developmental biology","volume":"23","author":"Castanon","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1074-7613(00)80392-1","article-title":"The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD","volume":"7","author":"Delovitch","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0096","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2005.08.002","article-title":"A comprehensive review of interventions in the NOD mouse and implications for translation","volume":"23","author":"Shoda","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0097","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1073\/pnas.93.6.2260","article-title":"Checkpoints in the progression of autoimmune disease: lessons from diabetes models","volume":"93","author":"Andre","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0098","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.040556697","article-title":"Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes","volume":"97","author":"Yu","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0099","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fendo.2018.00051","article-title":"The role of NOD mice in type 1 diabetes research: lessons from the past and recommendations for the future","volume":"9","author":"Chen","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0100","first-page":"37","article-title":"[Lipase activity and fat mobilization]","volume":"21","author":"Cosin","year":"1965","journal-title":"Rev Esp Fisiol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0101","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and beta-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0102","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial\u2014type 1","volume":"28","author":"Skyler","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0168-8227(94)90098-1","article-title":"Effects of difference in amount of exercise training on prevention of diabetes mellitus in the Otsuka-Long-Evans-Tokushima fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus","volume":"23","author":"Shima","year":"1994","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0104","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0140-6736(08)61309-4","article-title":"Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial","volume":"372","author":"Nanto-Salonen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.883000","article-title":"Preclinical models to evaluate the human response to autoantigen and antigen-specific immunotherapy in human type 1 diabetes","volume":"13","author":"Houeiss","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0106","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2251-6581-12-60","article-title":"Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans","volume":"12","author":"Eleazu","year":"2013","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0107","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr Protoc"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin-induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0109","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.180605","article-title":"Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus","volume":"193","author":"Like","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0111","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/diab.47.1.50","article-title":"GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice","volume":"47","author":"Wang","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0112","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3390\/biomedicines9121790","article-title":"Streptozotocin-induced diabetes in a mouse model (BALB\/c) is not an effective model for research on transplantation procedures in the treatment of type 1 diabetes","volume":"9","author":"Wszola","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111946","article-title":"Preclinical models of diabetic wound healing: a critical review","volume":"142","author":"Sanapalli","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1359685","article-title":"Animal models for type 1 and type 2 diabetes: advantages and limitations","volume":"15","author":"Singh","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/785948","article-title":"Nonhuman primate models of type 1 diabetes mellitus for islet transplantation","volume":"2014","author":"Zhu","year":"2014","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0116","doi-asserted-by":"crossref","first-page":"14546","DOI":"10.1038\/s41598-019-51199-5","article-title":"Establishment of a diabetes mellitus type 1 model in the common marmoset","volume":"9","author":"Yuan","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0117","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2002.tb02943.x","article-title":"Viruses and diabetes","volume":"958","author":"Jaeckel","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0118","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.3748\/wjg.v19.i42.7276","article-title":"Diagnosis and treatment of diabetes mellitus in chronic pancreatitis","volume":"19","author":"Ewald","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0119","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"D. consortium for the study of chronic pancreatitis, C. pancreatic, type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0120","first-page":"14","article-title":"Pancreatogenic type 3c diabetes: underestimated, underappreciated and poorly managed","volume":"163","author":"Duggan","year":"2017","journal-title":"Pract Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0121","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11248-009-9262-3","article-title":"Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs","volume":"18","author":"Umeyama","year":"2009","journal-title":"Transgenic Res"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0122","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.stemcr.2023.06.005","article-title":"Cell transplantation-based regenerative medicine in liver diseases","volume":"18","author":"Cardinale","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0123","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease \u2013 a practical approach for translational research","volume":"73","author":"Nevzorova","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0124","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bbrc.2020.03.148","article-title":"A nonhuman primate model of liver fibrosis towards cell therapy for liver cirrhosis","volume":"526","author":"Yasuda","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0125","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1038\/s41598-018-32889-y","article-title":"A pre-clinical large animal model of sustained liver injury and regeneration stimulus","volume":"8","author":"Inomata","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12929-016-0236-5","article-title":"Zebrafish and Medaka: new model organisms for modern biomedical research","volume":"23","author":"Lin","year":"2016","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0127","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1242\/dmm.050367","article-title":"Correction: medaka as a model for human nonalcoholic steatohepatitis","volume":"16","author":"Matsumoto","year":"2023","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/17474124.2020.1733975","article-title":"Clinical application of hepatocyte transplantation: current status, applicability, limitations, and future outlook","volume":"14","author":"Nguyen","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0129","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jhep.2019.12.002","article-title":"Alginate microencapsulated human hepatocytes for the treatment of acute liver failure in children","volume":"72","author":"Dhawan","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0130","first-page":"1","article-title":"Type-2 diabetes and gene therapy: the promise of CRISPR gene therapy in type-2 diabetes mellitus","volume":"1","author":"Khan","year":"2019","journal-title":"J Obes Manag"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0131","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jcyt.2014.05.018","article-title":"Human umbilical cord mesenchymal stromal cells rescue mice from acetaminophen-induced acute liver failure","volume":"16","author":"Liu","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0132","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/labinvest.2011.193","article-title":"Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver","volume":"92","author":"Knockaert","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117401","article-title":"Pretreatment of exosomes derived from hUCMSCs with TNF-\u03b1 ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage","volume":"246","author":"Zhang","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0134","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s40472-021-00325-2","article-title":"Cell therapy and bioengineering in experimental liver regenerative medicine: in vivo injury models and grafting strategies","volume":"8","author":"Amato","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MCG.0b013e31818a3854","article-title":"Acetaminophen hepatotoxicity and acute liver failure","volume":"43","author":"Chun","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0136","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2013 types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0137","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/17425255.2022.2122810","article-title":"Modeling drug-induced liver injury: current status and future prospects","volume":"18","author":"Di Zeo-Sanchez","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117401","article-title":"Pretreatment of exosomes derived from hUCMSCs with TNF-alpha ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage","volume":"246","author":"Zhang","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0139","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2011.01.030","article-title":"Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats","volume":"657","author":"Choi","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0140","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.3748\/wjg.v24.i45.5063","article-title":"Alcoholic liver disease: utility of animal models","volume":"24","author":"Lamas-Paz","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0141","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0142","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/019262339502300504","article-title":"Comparative changes in the liver of female fischer-344 rats after short-term feeding of a semipurified or a semisynthetic L-amino acid-defined choline-deficient diet","volume":"23","author":"Dai","year":"1995","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0143","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ajpath.2011.07.014","article-title":"Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis","volume":"179","author":"Itoh","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0144","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0145","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","article-title":"High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis","volume":"52","author":"Kohli","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0146","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2119\/molmed.2016.00203","article-title":"Induction of steatohepatitis (NASH) with insulin resistance in wild-type B6 mice by a western-type diet containing soybean oil and cholesterol","volume":"23","author":"Henkel","year":"2017","journal-title":"Mol Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0147","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0148","doi-asserted-by":"crossref","first-page":"12466","DOI":"10.1038\/srep12466","article-title":"Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis","volume":"5","author":"Saito","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0149","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1038\/s41598-018-27427-9","article-title":"Comparison of two protocols of carbon tetrachloride-induced cirrhosis in rats \u2013 improving yield and reproducibility","volume":"8","author":"Fortea","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0150","article-title":"Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis","volume":"96","author":"Tag","year":"2015","journal-title":"JoVE"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0151","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","article-title":"A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis","volume":"171","author":"Fickert","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0152","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/nu11102358","article-title":"Docosahexaenoic acid improves portal hypertension in a preclinical model of advanced chronic liver disease","volume":"11","author":"Boyer-Diaz","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0153","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0168-8278(85)80747-9","article-title":"A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat","volume":"1","author":"Jenkins","year":"1985","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0154","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0155","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41419-018-1136-2","article-title":"Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0156","first-page":"239","article-title":"Effect of rifaximin on hepatic fibrosis in bile duct-ligated rat model","volume":"70","author":"Shin","year":"2017","journal-title":"kjg"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0157","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/liv.12326","article-title":"Platelet increases survival in a model of 90% hepatectomy in rats","volume":"34","author":"L\u00f3pez","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0158","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.3748\/wjg.v18.i40.5709","article-title":"Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats","volume":"18","author":"Wang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0159","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1499-3872(13)60007-7","article-title":"Effects of xenogeneic adipose-derived stem cell transplantation on acute-on-chronic liver failure","volume":"12","author":"Zhu","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0160","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s10753-013-9805-x","article-title":"Inhibitions of NF-\u03baB and TNF-\u03b1 result in differential effects in rats with acute on chronic liver failure induced by d-gal and LPS","volume":"37","author":"Yang","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5301\/ijao.5000284","article-title":"Effects of coencapsulation of hepatocytes with adipose-derived stem cells in the treatment of rats with acute-on-chronic liver failure","volume":"37","author":"Zhang","year":"2014","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0162","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.dld.2014.06.008","article-title":"The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in rats","volume":"46","author":"Hu","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0163","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1390458","article-title":"Deregulation of regulatory T cells in acute-on-chronic liver failure: a rat model","author":"Ni","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0164","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopha.2017.04.117","article-title":"Adipose-derived mesenchymal stem cells slow disease progression of acute-on-chronic liver failure","volume":"91","author":"Gilsanz","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0165","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2018.07.022","article-title":"Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension","volume":"155","author":"Tripathi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0166","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/toxsci\/kfy292","article-title":"Histopathological and molecular signatures of a mouse model of acute-on-chronic alcoholic liver injury demonstrate concordance with human alcoholic hepatitis","volume":"170","author":"Furuya","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0167","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1111\/jcmm.14658","article-title":"Mitofusin2, a rising star in acute-on-chronic liver failure, triggers macroautophagy via the mTOR signalling pathway","volume":"23","author":"Xue","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0168","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.aohep.2019.03.007","article-title":"HIF1a inhibitor rescues acute-on-chronic liver failure","volume":"18","author":"Xie","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0169","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0170","first-page":"379","article-title":"Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation","volume":"70","author":"Sofia","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0171","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s12072-021-10244-0","article-title":"Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction","volume":"15","author":"Nautiyal","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0172","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101189","article-title":"Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats","volume":"5","author":"Hassan","year":"2022","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0173","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13287-021-02468-6","article-title":"Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling","volume":"12","author":"He","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0174","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.2147\/DDDT.S308713","article-title":"The Jieduan-Niwan (JDNW) formula ameliorates hepatocyte apoptosis: a study of the inhibition of E2F1-mediated apoptosis signaling pathways in acute-on-chronic liver failure (ACLF) using rats","volume":"15","author":"Hou","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0175","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3748\/wjg.v24.i18.1989","article-title":"Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma","volume":"24","author":"Takakura","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0176","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40139-017-0147-5","article-title":"Liver disease in alpha-1 antitrypsin deficiency: current approaches and future directions","volume":"5","author":"Mitchell","year":"2017","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0177","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2024.06.028","article-title":"Fazirsiran for adults with alpha-1 antitrypsin deficiency liver disease: a phase 2 placebo controlled trial (SEQUOIA)","volume":"167","author":"Clark","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0178","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0022-2836(86)90274-3","article-title":"Regulation of IncFII plasmid DNA replication. A quantitative model for control of plasmid NR1 replication in the bacterial cell division cycle","volume":"192","author":"Womble","year":"1986","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0179","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.ymthe.2023.06.018","article-title":"Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin","volume":"31","author":"Pastore","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0180","doi-asserted-by":"crossref","first-page":"e0070","DOI":"10.1097\/HC9.0000000000000070","article-title":"Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human alpha1-antitrypsin deficiency","volume":"7","author":"Li","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0181","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025242118","article-title":"Up-regulation of miR-34b\/c by JNK and FOXO3 protects from liver fibrosis","volume":"118","author":"Piccolo","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0182","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135348","article-title":"Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease","volume":"5","author":"Wooddell","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0183","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-0716-0704-6_9","article-title":"Engraftment of human hepatocytes in the PiZ-NSG mouse model","volume":"2164","author":"Tang","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0184","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/hum.2017.227","article-title":"Amelioration of alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice","volume":"29","author":"Shen","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192937","article-title":"Using machine-learning to optimize phase contrast in a low-cost cellphone microscope","volume":"13","author":"Diederich","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0186","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/cells8121586","article-title":"A novel small molecule inhibits intrahepatocellular accumulation of Z-variant alpha 1-antitrypsin in vitro and in vivo","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0187","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1164\/ajrccm.164.5.2010032","article-title":"Effects of cigarette smoke in mice with different levels of alpha (1)-proteinase inhibitor and sensitivity to oxidants","volume":"164","author":"Cavarra","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0188","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143004","article-title":"Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease","volume":"7","author":"He","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0189","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2019-319960","article-title":"Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure","volume":"70","author":"Yang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.stemcr.2015.04.017","article-title":"Amelioration of hyperbilirubinemia in gunn rats after transplantation of human induced pluripotent stem cell-derived hepatocytes","volume":"5","author":"Chen","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0191","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1016\/S0021-9258(18)52966-5","article-title":"Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans cinnamon mutant rat","volume":"268","author":"Yamada","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0192","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0193","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bbadis.2018.07.029","article-title":"In vitro and in vivo translational models for rare liver diseases","volume":"1865","author":"Haugabook","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0194","doi-asserted-by":"crossref","first-page":"24048","DOI":"10.1016\/S0021-9258(18)54390-8","article-title":"Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat)","volume":"266","author":"Iyanagi","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0195","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1074\/jbc.M709244200","article-title":"Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease","volume":"283","author":"Nguyen","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0196","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/bbrc.1994.1958","article-title":"The gene responsible for LEC hepatitis, located on rat chromosome 16, is the homolog to the human Wilson disease gene","volume":"202","author":"Sasaki","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0197","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3727\/000000006783982188","article-title":"Hepatocyte transplantation in the long Evans cinnamon rat model of Wilson's disease","volume":"15","author":"Park","year":"2006","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0198","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/lt.22466","article-title":"Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease","volume":"18","author":"Sauer","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0199","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/B978-0-444-63625-6.00006-9","article-title":"Animal models of Wilson disease","volume":"142","author":"Medici","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2007.11.012","article-title":"Chimeric mice with humanized liver","volume":"246","author":"Katoh","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0201","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007757","article-title":"Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice","volume":"2","author":"Brehm","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jcp.30610","article-title":"Liver-humanized mice: a translational strategy to study metabolic disorders","volume":"237","author":"Luo","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0203","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fimmu.2018.00746","article-title":"The use of the humanized mouse model in gene therapy and immunotherapy for HIV and cancer","volume":"9","author":"Carrillo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0204","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101417","article-title":"Modeling human T1D-associated autoimmune processes","volume":"56","author":"Khosravi-Maharlooei","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0205","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/db18-0202","article-title":"Humanized mouse model to study type 1 diabetes","volume":"67","author":"Luce","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0206","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.21873\/anticanres.14540","article-title":"The development of next-generation PBMC humanized mice for preclinical investigation of cancer immunotherapeutic agents","volume":"40","author":"Morillon","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0207","first-page":"4568","article-title":"Humanized mouse model: a review on preclinical applications for cancer immunotherapy","volume":"10","author":"Yin","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0208","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1096\/fj.201800636R","article-title":"Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression","volume":"33","author":"Brehm","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0209","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.1500971","article-title":"Plasmacytoid dendritic cell activation and IFN-\u03b1 production are prominent features of murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis","volume":"195","author":"Arai","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2011.06318.x","article-title":"Humanized mice for the study of type 1 and type 2 diabetes","volume":"1245","author":"Greiner","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.748679","article-title":"A humanized mouse strain that develops spontaneously immune-mediated diabetes","volume":"12","author":"Luce","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0212","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1710415114","article-title":"Type 1 diabetes induction in humanized mice","volume":"114","author":"Tan","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0213","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/stcltm\/szac053","article-title":"Stem cell therapies for chronic liver diseases: progress and challenges","volume":"11","author":"Li","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0214","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jhep.2020.09.014","article-title":"Cell therapy for advanced liver diseases: repair or rebuild","volume":"74","author":"Dwyer","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ilar.51.1.74","article-title":"The use of animal models to study stem cell therapies for diabetes mellitus","volume":"51","author":"Song","year":"2010","journal-title":"ILAR J"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0216","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4252\/wjsc.v14.i8.577","article-title":"Pancreatic transplant surgery and stem cell therapy: finding the balance between therapeutic advances and ethical principles","volume":"14","author":"Padovano","year":"2022","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0217","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/biomedicines9111695","article-title":"A novel cellular therapy to treat pancreatic pain in experimental chronic pancreatitis using human alpha-1 antitrypsin overexpressing mesenchymal stromal cells","volume":"9","author":"Chow","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0218","doi-asserted-by":"crossref","first-page":"e35785","DOI":"10.1016\/j.heliyon.2024.e35785","article-title":"Breaking the chain in organ failure: role of umbilical cord and bone marrow derived mesenchymal stem cells in treatment of severe acute pancreatitis","volume":"10","author":"Ren","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0219","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s10495-024-01946-5","article-title":"hP-MSCs attenuate severe acute pancreatitis in mice via inhibiting NLRP3 inflammasome-mediated acinar cell pyroptosis","volume":"29","author":"Lyu","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3164\/jcbn.15-56","article-title":"Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease","volume":"57","author":"Park","year":"2015","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0221","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9301382","article-title":"Pancreatic progenitors and organoids as a prerequisite to model pancreatic diseases and cancer","author":"Hohwieler","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0222","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10620-023-08189-5","article-title":"Bone marrow mesenchymal stem cells alleviate acute severe pancreatitis and promote lung repair via inhibiting NLRP3 inflammasome in rat","volume":"69","author":"Gong","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0223","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106128","article-title":"Resveratrol improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells in rats with severe acute pancreatitis","volume":"80","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0224","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.ymthe.2017.06.016","article-title":"Adipose stem cell therapy mitigates chronic pancreatitis via differentiation into acinar-like cells in mice","volume":"25","author":"Sun","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5152\/tjg.2020.19143","article-title":"Stem cell therapy: a potential for the perils of pancreatitis","volume":"31","author":"Chela","year":"2020","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0226","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109408","article-title":"Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice","volume":"113","author":"Yu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0227","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00204-022-03372-5","article-title":"Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts","volume":"96","author":"Umbaugh","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0228","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.biopha.2018.09.138","article-title":"Gene therapy and type 1 diabetes mellitus","volume":"108","author":"Chellappan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0229","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5483\/BMBRep.2022.55.6.033","article-title":"Therapeutic applications of gene editing in chronic liver diseases: an update","volume":"55","author":"Shin","year":"2022","journal-title":"BMB Rep"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molmet.2017.05.007","article-title":"AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice","volume":"6","author":"Mallol","year":"2017","journal-title":"Mol Metabol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0231","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1189\/jlb.3A0815-371RRR","article-title":"Reg3g overexpression promotes \u03b2 cell regeneration and induces immune tolerance in nonobese-diabetic mouse model","volume":"99","author":"Xia","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0232","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14712598.4.4.507","article-title":"Hepatocyte growth factor gene therapy for islet transplantation","volume":"4","author":"Rao","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0233","series-title":"Pancreatitis associated with genetic risk factors","first-page":"29","volume":"26","author":"Schwarzenberg","year":"2023"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0234","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/gutjnl-2023-330788","article-title":"Pancreas-directed AAV8<em>-hSPINK1<\/em>gene therapy safely and effectively protects against pancreatitis in mice","volume":"73","author":"Wang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0235","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.7150\/ijbs.33481","article-title":"CRISPR\/Cas9-related technologies in liver diseases: from feasibility to future diversity","volume":"16","author":"Xu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0236","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.stem.2024.04.022","article-title":"Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases","volume":"31","author":"Zhang","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2024.11.008_bib0237","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2019.03.021","article-title":"Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice","volume":"71","author":"Aronson","year":"2019","journal-title":"J Hepatol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:24:44Z","timestamp":1744446284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924009344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":237,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1465324924009344"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.11.008","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}